next level tirzepatide Why is changing the conversation around metabolic health? Unlike medications that target only GLP-1, tirzepatide works on both GLP and GIP receptors, which is part of what makes it so effective Tirzepatide Injections & Treatment in

Weight-based dosing challenges, accelerated drug clearance, and adipose-driven immune activation all conspire to undermine therapeutic response

metformin 0.5 grams three times a day

Canadian Employer Plans Covering GLP-1s for Weight Loss Have Nearly Doubled Data from the International Foundation of Employee Benefit Plans (IFEBP) 2025 Pulse Survey shows a significant shift in Canadian employer attitudes toward GLP-1 coverage: 31% of employer plans now cover GLP-1s for weight loss (up from 17% in 2024) 56% cover for diabetes only (down from 66% in 2024) 20% of diabetes-only plans are considering adding obesity coverage Provincial public drug plans still cover semaglutide only for type 2 diabetes not for weight loss

Thats because weight change is often roughly proportional to starting weight

Essentially, die off happens when the death of infecting cells creates toxins and an immune reaction as your body tries to remove the toxins

We are in a new era for obesity pharmacotherapy where combinations of entero-pancreatic hormones approach the WL achieved with bariatric surgery